跳至主要内容
临床试验/DRKS00030400
DRKS00030400招募中4 期

Pilot study to evaluate glycemic control using GlucoTab in combination with continuous glucose monitoring in non-critically ill patients with type 2 diabetes at the general ward - GlucoMenDay_GlucoTab

Medizinische Universität Graz0 个研究点目标入组 30 人开始时间: 2022年9月30日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Informed consent obtained after being advised
  • of the nature of the study
  • -Male or female aged =18 years
  • -Type 2 diabetes (treated with diet, oral agents,
  • non-insulin injected anti-diabetic medicine,
  • insulin therapy or any combination of the four)
  • or newly diagnosed hyperglycemia which
  • requires s.c. insulin therapy

排除标准

  • - Type 1 diabetes, gestational diabetes
  • - Any disease or condition which the
  • investigator or treating physician feels would
  • interfere with the trial or the safety of the
  • - Hyperglycaemic episodes (ketoacidosis,
  • hyperosmolar state) if they require intravenous
  • insulin therapy
  • - Pregnancy
  • - Any mental condition rendering the patient
  • incapable of giving his consent
  • - Known or suspected allergy to adhesive
  • material/tape
  • - Skin pathologies that hinder application of a
  • - Continuous parenteral nutrition
  • - Participation in another trial which can
  • influence outcome of the trial

研究者

相似试验